A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Summary
S4875, introduced by Sen. Bennet (D-CO), authorizes a program to develop innovative antimicrobial drugs targeting challenging pathogens. The bill is in early legislative stages (referred to committee) with no specified funding amount, limiting near-term market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Bill is at earliest legislative stage (referred to committee) with no funding amount.
- 2.No specific companies are directly impacted yet; broad antimicrobial sector could see tailwinds if funded.
- 3.Limited cosponsorship (4) reduces probability of swift passage.
Market Implications
The bill currently has no material market implications. Antimicrobial drug developers may eventually benefit if federal grants are authorized and appropriated, but that is a multi-step process with uncertain outcomes. No stock price movements are justified by this early-stage procedural action.
Full Analysis
S4875, the bill to amend the Public Health Service Act to establish an antimicrobial drug development program, was introduced on June 23, 2026, and referred to the Senate Committee on Health, Education, Labor, and Pensions. As an authorization bill, it sets policy but does not appropriate funds; actual spending requires a separate appropriations bill. No funding level is specified, and the bill has only 4 cosponsors, suggesting limited legislative momentum. The antimicrobial drug market is served by large pharma (e.g., $MRK, $PFE) and small biotechs, but the bill's early stage and lack of appropriations mean no direct revenue impact is currently estimable. The legislative path includes committee hearings, potential markup, and floor votes, followed by any companion House bill. Given the procedural stage and no funding commitment, the market implications are minimal. Investors should monitor committee activity and future appropriations language for concrete opportunities.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A bill to authorize workforce development innovation grants for the implementation, expansion, and evaluation of evidence-based workforce programs, and for other purposes.
PASTEUR Act of 2026
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →